Kamada KMDA
NASDAQ KMDA
$8.46 -0.23 (-2.65%)
At close: Sep 30, 2026 · 4:00 PM EDT

Kamada (KMDA) Other Non-Current Liabilities (2012 - 2026)

Updated

Kamada's Other Non-Current Liabilities was $28.96 million in the quarter ended Jun 30, 2026, down 11.7% from $32.78 million a year earlier and down 3.2% from the prior quarter.

Analysis

Kamada (KMDA) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends

As of Dec 31, 2025, Other Non-Current Liabilities at Kamada came in at $30.11 million, down 8.2% from the prior year.

  • Other Non-Current Liabilities has now declined for four consecutive years, with a four-year compound annual growth rate of -9.0% (years ended Dec 2021 to Dec 2025).
  • In earlier years, Other Non-Current Liabilities was $32.82 million in the year ended Dec 31, 2024 (-4.5%), $34.38 million in the year ended Dec 31, 2023 (-7.9%), $37.31 million in the year ended Dec 31, 2022 (-15.1%) and $43.93 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Other Non-Current Liabilities since the quarter ended Dec 31, 2012.
  • Compared with a year earlier, Other Non-Current Liabilities has declined for 15 straight quarters, with an average decline of 6.8% over the last eight quarters.
  • The year-over-year decline in Other Non-Current Liabilities has ranged between 4.3% (the quarter ended Jun 30, 2025) and 15.1% (the quarter ended Dec 31, 2022) over the last five years.
  • Per Business Quant data, KMDA's Other Non-Current Liabilities in the three quarters before the quarter ended Jun 30, 2026 was $29.93 million (quarter ended Mar 31, 2026), $30.11 million (quarter ended Dec 31, 2025) and $32.54 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Kamada 488.02 Mn 197.08 Mn 22.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.96 Mn
Mar 31, 2026 29.93 Mn
Dec 31, 2025 30.11 Mn
Sep 30, 2025 32.54 Mn
Jun 30, 2025 32.78 Mn
Mar 31, 2025 32.99 Mn
Dec 31, 2024 32.82 Mn
Sep 30, 2024 34.12 Mn
Jun 30, 2024 34.24 Mn
Mar 31, 2024 34.84 Mn
Dec 31, 2023 34.38 Mn
Sep 30, 2023 36.48 Mn
Jun 30, 2023 36.51 Mn
Mar 31, 2023 37.28 Mn
Dec 31, 2022 37.31 Mn
Sep 30, 2022 39.92 Mn
Jun 30, 2022 41.30 Mn
Mar 31, 2022 42.53 Mn
Dec 31, 2021 43.93 Mn
Dec 31, 2012 23,000.00
API Access

Kamada Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KMDA&period=max&api_key=YOUR_API_KEY